ProShares UltraPro Nasdaq Biotechnology is a ETF series of ProShares Trust (series S000049733). Net assets $20.2M as of 2020-02-29. Index fund.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Gilead Sciences, Inc. | — | $1.6M | 776.55% |
| Vertex Pharmaceuticals, Inc. | — | $1.3M | 651.98% |
| Amgen, Inc. | — | $1.3M | 640.51% |
| Biogen, Inc. | — | $1.3M | 629.73% |
| Regeneron Pharmaceuticals, Inc. | — | $917K | 453.47% |
| Illumina, Inc. | — | $894K | 441.88% |
| Total Return Swap | — | $708K | 350.01% |
| Alexion Pharmaceuticals, Inc. | — | $482K | 238.55% |
| Seattle Genetics, Inc. | — | $452K | 223.72% |
| Incyte Corp. | — | $377K | 186.20% |
| BioMarin Pharmaceutical, Inc. | — | $376K | 186.10% |
| Alnylam Pharmaceuticals, Inc. | — | $304K | 150.38% |
| Sanofi | — | $224K | 110.70% |
| Mylan NV | — | $206K | 101.71% |
| Neurocrine Biosciences, Inc. | — | $202K | 99.97% |
| Report date | Net assets |
|---|---|
| 2020-02-29 | $20.2M |
| 2019-11-30 | $27.3M |